Research News and Research

RSS

Neoprobe submits BLA response letter to FDA to commercialize RIGS technology

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has submitted a response letter to the U.S. Food and Drug Administration (FDA) regarding its RIGScan technology Biologic License Application (BLA).

22 Oct 2010

Rising cost of long-term care threatens state, federal budgets

The Fiscal Times reports on the surging costs of long-term care, "which amount to a fiscal time bomb for states and the federal government."

22 Oct 2010

Clinical research scholar receives grant to promote lifestyle changes for HIV patients

Between the demands of work, family and friends, many women find health takes a back seat. Women with HIV are no exception. "Many women with the HIV face challenges from sleepless nights to little personal time-all activities that can negatively impact health," says Allison Webel, a clinical research scholar and instructor at the Frances Payne Bolton School of Nursing at Case Western Reserve University.

22 Oct 2010

Malaria deaths in India 13 times higher than WHO estimate, study says

"Malaria kills around 205,000 people in India each year, more than 13 times the estimate made by the World Health Organization, researchers said on Thursday," Reuters reports.

22 Oct 2010

State races take on health care tone as candidates talk overhaul

The health overhaul is making itself felt in political races around the country.

22 Oct 2010

Insurance commissioners to vote on spending requirements

The National Association of Insurance Commissioners will make a final vote on its recommendations for regulating how much insurers must spend on medical services, a key health law provision, Kaiser Health News reports.

22 Oct 2010

Atherotech to present VAP Cholesterol Test at OMED 2010

Atherotech Diagnostics Lab will showcase its VAP Cholesterol Test in booth 324 at the American Osteopathic Association's 115th Annual Osteopathic Medical Conference & Exposition (OMED 2010). The gathering of DOs, residents, interns, students, researchers and health care professionals will be held October 24-28 at Moscone Convention Center in San Francisco.

22 Oct 2010

Celtic Pharma receives US patent for methods to treat breast, colon cancer

Celtic Pharmaceutical Holdings L.P. today announced that the U.S. Patent Office has issued U.S. patent 7,816,323, for novel methods to treat breast and colon cancers using a combination therapy of Xerecept with Avastin.

22 Oct 2010

Today's OpEds: Orszag on malpractice reform; debate over individual mandate; insurers' hard-ball tactics

Opponents of the act are generally off base in criticizing investments in improved care. In complaining about the missed opportunity to reform medical malpractice laws to promote evidence-based medical practice, on the other hand, the critics are entirely on target.

22 Oct 2010

Pinch of salt: How much is enough?

Salt restriction in the normal diet has come under debate. While scientists are questioning the complex role of sodium in the body and the need for salt restriction, surveys have found that dietary sodium has not gone down well in large populations despite awareness on the risks of too much salt intake.

21 Oct 2010

Potential SIDS cause found

A baffling condition Sudden Infant Death Syndrome (SIDS) that leads to the unexplained deaths of many infants worldwide may have been explained in new Australian research. The researchers monitored babies as they slept on their bellies and found that they have reduced blood pressure and an increased heart rates, compared with when they slept on their backs as recommended. This effect is seen more in babies aged two to three months, the age when babies are most at risk of SIDS.

21 Oct 2010

$1 million Pfizer Fellowship awarded for melanoma research at AusBiotech 2010

Dr Mark Shackleton was last night awarded the 2011 Pfizer Australia Senior Research Fellowship grant for his research proposal at the AusBiotech 2010 Conference Dinner. Professor John Funder, chair of the selection committee, announced this year’s winner, who will use the $1 million, five-year Fellowship for research into ‘Identifying determinants of human melanoma progression’.

21 Oct 2010

Australian stem cell line offers fresh approach to diabetes cure

Australian researchers have developed the country’s first diabetes specific stem cell line, a major advance for patients suffering from the chronic disease.

21 Oct 2010

Lodestone Clinical Trials Supply Management solution achieves 'Powered By SAP Netweaver' certification

Lodestone Management Consultants today announced the new software release 1.0 of its Clinical Trials Supply Management (CTSM) Add-On Suite®. The solution has achieved SAP certification as powered by the SAP NetWeaver® technology platform, providing more transparency and a reduction of overages in the complex and time-consuming clinical development process of which the clinical supply chain is a key component.

21 Oct 2010

Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study

Results of a new international phase 4 study of patients with nosocomial pneumonia due to proven methicillin-resistant Staphylococcus aureus (MRSA) demonstrated that the antibiotic Zyvox® (linezolid) achieved a statistically significantly higher clinical success rate compared with vancomycin for the primary endpoint. The ZEPHyR (Linezolid in the treatment of subjects with nosocomial pneumonia proven to be due to methicillin-resistant Staphylococcus aureus) study was the largest ever conducted in this population.

21 Oct 2010

Bruker installs BioSpec 170/25 system at CEA NeuroSpin research center

Bruker announced today that it has successfully installed its BioSpec® 170/25 system at the CEA NeuroSpin research center near Paris, France. The world's first horizontal ultra-high magnetic field 17.2 Tesla MRI system features a magnet bore diameter of 25 cm. It is equipped with a novel Bruker BGA-S™ gradient system with unsurpassed amplitude and slew rate specifications for cutting-edge preclinical in vivo imaging on small animals.

21 Oct 2010

PolyMedix plans PMX-60056 Phase 2 clinical trial in interventional cardiology

PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has announced plans for a Phase 2 clinical trial of PMX-60056 in interventional cardiology, and the establishment of a focused Heptagonist Clinical Advisory Board (CAB). PMX-60056 is a synthetic small-molecule designed to reverse the anticoagulant activity of heparin and low molecular weight heparins (LMWH).

21 Oct 2010

Kensey Nash 2011 first quarter decreases 14% to $17.0 million

Kensey Nash Corporation , a medical device company primarily focused on regenerative medicine for a wide range of medical procedures, today reported the results for its first quarter ended September 30, 2010.

21 Oct 2010

First Edition: October 21, 2010

Today's headlines include news about how opponents of the health law are steering the educational efforts that surround it, as well as poll results that suggest continued Republican inroads at the polls.

21 Oct 2010

North Carolina Academic Center to conduct youth violence prevention research

North Carolina will be home to the nation's first rurally focused youth violence prevention center, with a federal grant worth nearly $6.5 million to support a new project based in Robeson County and led by University of North Carolina at Chapel Hill researchers.

21 Oct 2010